Interleukin-4 and interleukin-13 as possible therapeutic targets in systemic sclerosis

G Gasparini, E Cozzani, A Parodi - Cytokine, 2020 - Elsevier
Systemic sclerosis (SSc) is an autoimmune disease characterized by fibrosis of skin and
internal organs. Its pathogenesis, which is still poorly understood, features three main …

Interleukin-6 and type-I collagen production by systemic sclerosis fibroblasts are differentially regulated by interleukin-17A in the presence of transforming growth …

AM Dufour, M Alvarez, B Russo… - Frontiers in …, 2018 - frontiersin.org
Functional cytokine networks have been poorly characterized in systemic sclerosis (SSc).
While interleukin-17A (IL-17A) is increased in SSc skin and other organs, its role is still …

Immunological basis of systemic sclerosis

JP Zuber, F Spertini - Rheumatology, 2006 - academic.oup.com
Systemic sclerosis (SSc) is a disease of unknown aetiology characterized by excessive and
often progressive fibrosis in skin and multiple internal organs, an aberrant immune activation …

Interleukin‐13–producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis

P Fuschiotti, AT Larregina, J Ho… - Arthritis & …, 2013 - Wiley Online Library
Objective Fibrosis is a major contributor to morbidity and mortality in systemic sclerosis
(SSc). T cells are the predominant inflammatory infiltrate in affected tissue and are thought to …

Interleukin‐6: a new therapeutic target in systemic sclerosis?

S O'reilly, R Cant, M Ciechomska… - Clinical & …, 2013 - Wiley Online Library
Interleukin‐6 (IL‐6) is a classic pro‐inflammatory cytokine critical in mounting an effective
immune response. It is secreted by a wide array of cell types; however, its effector cells are …

Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin‐13 associated with increased skin fibrosis

P Fuschiotti, TA Medsger Jr… - Arthritis & Rheumatism …, 2009 - Wiley Online Library
Objective T lymphocytes play an important role in systemic sclerosis (SSc), a connective
tissue disease characterized by inflammation, fibrosis, and vascular damage. While their …

New developments in the pathogenesis of systemic sclerosis

LI Sakkas - Autoimmunity, 2005 - Taylor & Francis
Systemic sclerosis (SSc) is characterized by extensive fibrosis, vasculopathy and activation
of the immune system. Fibrosis can be caused by profibrotic cytokines, such as transforming …

Current perspectives on the role of CD8+ T cells in systemic sclerosis

P Fuschiotti - Immunology letters, 2018 - Elsevier
Despite long-standing recognition of the importance of T cells in systemic sclerosis (SSc;
scleroderma), the role of CD8+ T cells in disease pathogenesis has not been well studied …

Interleukin-6, its role in fibrosing conditions

S O'Reilly, M Ciechomska, R Cant, T Hügle… - Cytokine & growth factor …, 2012 - Elsevier
Interleukin-6 is a classic pro-inflammatory cytokine needed to mount an effective immune
response. It is secreted by a wide array of cell types, however, its target cells are more …

Role of anti-inflammatory cytokines IL-4 and IL-13 in systemic sclerosis

XL Huang, YJ Wang, JW Yan, YN Wan, B Chen… - Inflammation …, 2015 - Springer
Objective The aim of this paper is to review the anti-inflammatory cytokines IL-4 and IL-13
and their receptor signals; we discuss new insight into their possible roles in systemic …